ReVIVE for mTBI: Using VR and therapy to help adults with mild traumatic brain injury
Official title: Rehabilitation Through Virtual Immersion & Integrated Exposure for Mild Traumatic Brain Injury (ReVIVE for mTBI)
Run by Johns Hopkins University · NCT07890337 · Data updated 2026-11-12
This study tests a virtual reality therapy combined with standard psychotherapy to see if it can reduce PTSD symptoms and improve executive function in adults with mild traumatic brain injury.
Quick facts
| Phase | Phase 1 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 55 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Johns Hopkins University Academic / other |
| Locations | 1 site (Baltimore, Maryland) |
| Status | Recruiting |
| Started | October 2026 |
| Main results expected | May 2027 |
| Study ends | May 2028 |
| Registry record updated | October 26, 2026 |
| Trial ID | NCT07890337 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults up to age 55 with a history of one or more concussions and mild-to-moderate PTSD symptoms (DTS 20–44) who are already receiving or have recently received standard care for mTBI or PTSD.
✕Probably not a fit
Individuals with severe psychiatric disorders, active substance abuse, epilepsy or other major neurological diseases, or age above 55 may not benefit or participate safely.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This Phase 1 trial investigates an integrated treatment that blends virtual reality exposure with standard psychotherapy for adults who have mild traumatic brain injury and PTSD symptoms. Participants will receive VR-based interventions alongside ongoing psychotherapeutic care to target hyperarousal and hypervigilance. The study uses the Davidson Trauma Scale to measure changes in PTSD symptoms, particularly hyperarousal. Recruitment is limited to adults with a history of concussion and current PTSD symptoms, who are receiving or have recently received evidence-based treatments. The research is conducted at Johns Hopkins Bayview Medical Center in Baltimore, under Johns Hopkins University as lead sponsor.
Why it matters
Potential benefit: If successful, participants may experience reductions in PTSD symptoms and improvements in cognitive and emotional regulation related to mTBI.
How similar studies have gone: Prior research suggests that VR-assisted therapies and exposure-based approaches can reduce PTSD symptoms in related populations, supporting exploration of this combined modality.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: * History of one or more concussions. * Presence of mild-to-moderate PTSD symptoms, defined as a score between 20 and 44 on the Davidson Trauma Scale (DTS), indicating clinically relevant but not severe symptomatology (Davidson et al., 1997). * Prior or ongoing therapy, defined as current or recent (within the last 3 months) engagement in standard care treatments such as psychiatric medication management, and evidence-based psychotherapy targeting mTBI or PTSD symptoms. * Prior U.S military service (any duration and any branch) is required for eligibility. Exclusion criteria: * Age over 55 to reduce confounding effects of age-related neurodegeneration and cognitive decline. * Diagnosis of severe psychiatric disorders (e.g., schizophrenia, bipolar disorder). * Active substance abuse. * Presence of unrelated neurological conditions such as epilepsy, stroke, seizure disorders, or neurodegenerative diseases (e.g., Alzheimer's, Parkinson's). * Significant cognitive impairment, assessed by standardized cognitive screening, which would interfere with the ability to participate fully in VR and therapy sessions. * Physical impairments that would prevent safe engagement in VR and therapy.
Where it's running
-
Johns Hopkins Bayview Medical Center - Pyschiatry
Baltimore, Maryland, United States Recruiting
Study contacts
- Principal investigator: Durga Roy, MD — Johns Hopkins University
- Study coordinator: Saumik Das
- Email: sdas41@jh.edu
- Phone: 703-554-0332
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Group-based Emotional Awareness and Expression Therapy to Support Recovery After Acquired Brain Injury
A group therapy program based on EAET is tested to see if it helps adults 18-65 with acquired brain injury improve emotional well-being and daily functioning.
-
COMP360 psilocybin for PTSD: see if it helps reduce symptoms with guided support
This study tests COMP360 (a lab-made psilocybin) to see if it can help reduce PTSD symptoms in adults, with supervision from a trained team.
-
Hyperbaric oxygen for thinking, mental health, and quality of life in veterans
This trial will try hyperbaric oxygen therapy to see if it improves thinking, PTSD symptoms, mood, anxiety, and overall quality of life in veterans with mild TBI or related conditions.
-
Virtual Reality–Assisted Trauma-Focused CBT for PTSD
A VR-assisted trauma-focused CBT approach is being tested to see if it helps adults with PTSD related to Northern Ireland–specific trauma.
-
HBOT to see if it helps cognition and well‑being in first responders with prior brain injury
This study tests whether 40 hyperbaric oxygen therapy sessions can improve thinking skills and post-concussion symptoms in current or former first responders with a history of brain injury.
-
Predicting nightmare awakenings in PTSD using an AI algorithm
The study tests an AI tool called CAUD-PIN to see if it can reliably predict when trauma-related nightmares will wake military personnel or veterans with PTSD.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.